Trials / Unknown
UnknownNCT02137187
Atrioventricular Junction Ablation and Biventricular Pacing for Atrial Fibrillation and Heart Failure
A Randomized Controlled Trial of Atrioventricular (AV) Junction Ablation and Biventricular Pacing Versus Optimal Pharmacological Therapy in Patients With Permanent Atrial Fibrillation
- Status
- Unknown
- Phase
- Phase 3
- Study type
- Interventional
- Enrollment
- 1,830 (estimated)
- Sponsor
- Centro Prevenzione Malattie Cardiovascolari N. e V. Corbella · Academic / Other
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
There is evidence of superiority of AV junction ablation strategy over pharmacological therapy only for symptoms of atrial fibrillation, but not for heart failure, hospitalization, morbidity and mortality. Hypothesis of trial is that AV junction ablation is superior to pharmacological therapy as regard hospitalization and mortality
Detailed description
Prospective randomized, controlled, investigator-initiated trial which consists of two specific consecutive(overlapped) phases: "Morbidity trial" (APAF-CRT morbidity). Small size (280 pts), follow-up 24 months. Primary endpoint: combined of mortality due to heartfailure, hospitalization for heart failure or atrial fibrillation or worsening heart failure. Predefined subgroup analysis for patients with ejection fraction ≤35% versus \>35% "Mortality trial" (APAF-CRT mortality). Large size (pts included in morbidity trial plus additional \~1500 pts, long-term follow-up (at least 4 years). Primary endpoint: total mortality. Predefined subgroup analysis for patients with ejection fraction ≤35% versus \>35%
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| PROCEDURE | AV junction ablation | AV junction ablation |
| DEVICE | CRT | Implantation of device for pacing and cardiac resynchronization therapy (CRT-P or CRT-D according to guidelines) |
| DRUG | Optimized drug therapy | Optimized drug therapy for heart failure and atrial fibrillation rate control |
| DEVICE | ICD | Implantable defibrillator (in control Group or in association with CRT in study Group) according to guidelines |
Timeline
- Start date
- 2014-10-15
- Primary completion
- 2021-05-15
- Completion
- 2021-07-31
- First posted
- 2014-05-13
- Last updated
- 2021-01-20
Locations
1 site across 1 country: Italy
Source: ClinicalTrials.gov record NCT02137187. Inclusion in this directory is not an endorsement.